Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solesence (SLSN) EBT: 2010-2025

Historic EBT for Solesence (SLSN) over the last 16 years, with Sep 2025 value amounting to -$1.1 million.

  • Solesence's EBT fell 136.78% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 36.90%. This contributed to the annual value of $4.5 million for FY2024, which is 201.78% up from last year.
  • As of Q3 2025, Solesence's EBT stood at -$1.1 million, which was down 136.64% from $3.1 million recorded in Q2 2025.
  • Solesence's 5-year EBT high stood at $3.1 million for Q2 2025, and its period low was -$2.1 million during Q4 2023.
  • Over the past 3 years, Solesence's median EBT value was $80,000 (recorded in 2025), while the average stood at $190,545.
  • As far as peak fluctuations go, Solesence's EBT spiked by 884.43% in 2021, and later tumbled by 1,969.35% in 2023.
  • Quarterly analysis of 5 years shows Solesence's EBT stood at -$357,000 in 2021, then slumped by 460.78% to -$2.0 million in 2022, then fell by 5.99% to -$2.1 million in 2023, then surged by 84.40% to -$331,000 in 2024, then tumbled by 136.78% to -$1.1 million in 2025.
  • Its last three reported values are -$1.1 million in Q3 2025, $3.1 million for Q2 2025, and $80,000 during Q1 2025.